KYNTRA BIO INC (KYNB) Stock Income Statement
NASDAQ:KYNB • US31572Q8814
6.93 USD
-0.04 (-0.57%)
Last: Feb 27, 2026, 08:15 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.30M | 29.62M | 46.80M | 140.70M | 235.30M | |||
| Cost Of Goods | -20.39M | 15.56M | 3.96M | 20.30M | 12.90M | |||
| Gross Profit | 28.68M | 14.06M | 42.84M | 120.50M | 222.40M | |||
| Operating Expenses | 151.26M | 145.02M | 352.96M | 421.50M | 510.90M | |||
| Research and Development | 17.73M | 95.69M | 266.47M | 296.80M | 387.00M | |||
| Selling, General, and Administrative Expenses | 7.14M | 50.45M | 89.51M | 127.50M | 120.60M | |||
| Operating Income | -122.58M | -130.96M | -310.12M | -301.00M | -288.50M | |||
| Interest Income/Expense | 2.01M | -2.95M | -501.00K | 6.20M | -2.20M | |||
| Non Recurring Items | -8.04M | -19.45M | -12.61M | N/A | N/A | |||
| Income Before Taxes | -128.61M | -153.37M | -323.22M | -294.90M | -290.70M | |||
| Income Tax | -142.00K | -269.00K | -252.00K | 400.00K | 300.00K | |||
| Net Income | 215.65M | -47.58M | -284.23M | -293.70M | -290.00M | |||
| EBITDA | -121.49M | -128.27M | -300.19M | -290.40M | -273.69M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 53.32 | -11.88 | -73.02 | -78.46 | -78.50 | |||
| Non GAAP EPS | 0.62 | -12.00 | -70.00 | -78.50 | -78.50 | |||
| Statistics | ||||||||
| Gross Profit Margin | 345.69% | 47.47% | 91.53% | 85.64% | 94.52% | |||
| Profit Margin | 2598.87% | -160.63% | -607.29% | -208.74% | -123.25% | |||
| Operating Profit Margin | -1477.21% | -442.13% | -662.60% | -213.93% | -122.61% | |||
All data in USD